[Preventing weight gain in smoking cessation: there is no miracle solution].
Nanchen
David
D
Institut de médecine sociale et preventive, CHUV et Université de Lausanne, Bugnon 17, 1005 Lausanne.
Willi
Carole
C
Peytremann-Bridevaux
Isabelle
I
Burnand
B
B
Walther
M Rège
MR
D000328:Adult; D016642:Bupropion / Q000627:therapeutic use; D018765:Dopamine Uptake Inhibitors / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D009271:Naltrexone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D010353:Patient Education as Topic; D012306:Risk; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D016540:Smoking Cessation / Q000379:methods*; D013375:Substance Withdrawal Syndrome / Q000517:prevention & control*; D015430:Weight Gain
D016642:Bupropion; D018765:Dopamine Uptake Inhibitors; D005473:Fluoxetine; D009271:Naltrexone; D009292:Narcotic Antagonists; D017367:Selective Serotonin Reuptake Inhibitors